One of the biggest challenges is the complexity of the LRRK2 protein and its multiple roles in cellular function. Moreover, the variability in clinical symptoms among patients with LRRK2 mutations makes it difficult to develop a one-size-fits-all treatment. Additionally, long-term studies are needed to assess the efficacy and safety of potential treatments targeting LRRK2.
